Clinical Trial

Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this project is to evaluate the effect of bioactive compound sources, propolis and royal jelly, on metabolomics, inflammation, and cardiovascular risk markers in participants with coronary artery disease. A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.
Trial Details
NCT Number NCT07596992
Lead Sponsor Universidade Federal Fluminense
Collaborators: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Conditions Coronary Artery Disease (CAD), Oxidative Stress, Inflammation
Enrollment 50 participants
Start Date 2026-05-18
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-19